MedPath

Investigating the effect of two probiotic strains on the symptoms of polycystic ovary syndrome

Phase 3
Conditions
Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20121216011763N62
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
90
Inclusion Criteria

Patients who agree to participate in the study.
- Diagnosis of polycystic ovary syndrome by obstetrician and gynecologist according to the Rotterdam criteria

Exclusion Criteria

- Pregnancy and breastfeeding
- Consumption of probiotic supplements or products during the last four weeks
- Suffering from mental illnesses (major depression, bipolar disorder, and schizophrenia) based on the patient's statement or history of hospitalization in a mental hospital or history of taking psychoactive drugs
- Hyperprolactinemia
Menopause
Uncontrolled diabetes(according to glycosylated hemoglobin index, 8% = HbA1C)
Suffering from chronic diseases such as cardiovascular, liver, kidney, neoplasm
Performing laparoscopic surgery of ovaries and assisted reproduction technology

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath